The mechanism of action of macrophage colony-stimulating factor (M-CSF) in osteoclast development was examined in a co-culture system of mouse osteoblastic cells and spleen cells. 
Introduction
It is well established that osteoclasts, multinucleated giant cells responsible for bone resorption, are derived from hemopoietic progenitors (1) . Over the past few years, many attempts have been made to reveal the mechanism of osteoclast formation, and several in vitro systems for examining osteoclast formation have been developed (2) (3) (4) (5) . We previously reported that osteo-clast-like multinucleated cells (MNCs)' were formed when mouse spleen cells were co-cultured with primary osteoblastic cells, obtained from mouse calvaria, in the presence ofbone-resorbing agents such as la,25(OH)2D3, PTH, and PGs (6) . Like authentic osteoclasts, MNCs formed in our co-culture system were positive for tartrate-resistant acid phosphatase (TRAP), possessed a number of calcitonin receptors, had ruffled borders and clear zones, and formed resorption pits on dentine slices (6) .
In a previous report (7), we showed that not only mouse spleen cells but also blood monocytes and alveolar macrophages formed single cell-derived colonies on the marrow-derived stromal ST2 cell layers. All of the colonies consisted of mainly nonspecific esterase (a macrophage marker enzyme)-positive cells, and TRAP-positive cells also appeared in the colonies in response to 1 a,25 (OH )2D3 and dexamethasone (7) . These results suggest that osteoclasts are derived from cells of the monocyte-macrophage lineage. This hypothesis is supported by the recent finding that osteoclast deficiency in osteopetrotic (op/op) mice is due to an inability to produce functionally active macrophage colony-stimulating factor (M-CSF, also known as colony-stimulating factor-1) (8, 9) . Yoshida et al. clearly demonstrated an extra thymidine insertion at bp No. 262 in the coding region of the M-CSF gene in op/op mice, which generated a TGA stop codon, 21 bp downstream (10) . Almost simultaneously, it was shown that administration of recombinant human M-CSF to op/op mice cured their osteopetrotic bone disorders (11) . This in vivo observation was quickly confirmed by Kodama et al. ( 12) and Wiktor-Jedrzejczak et al. ( 13) . We also reported that osteoblastic cells obtained from op/op mice could not support osteoclast differentiation in co-cultures with normal spleen cells ( 14) . Adding M-CSF together with 1 a,25 (OH )2D3 induced osteoclast-like MNCs in co-cultures with op/op osteoblastic cells ( 14) . These findings strongly indicate that M-CSF produced by osteoblastic cells plays a critical role in osteoclast development.
In 1986, MacDonald et al. reported that M-CSF stimulated osteoclast-like cell formation in human bone marrow cultures ( 15 ) . More recently, we demonstrated that M-CSF effectively stimulates proliferation of osteoclast progenitors, but that this effect can be duplicated by other hemopoietic growth factors such as GM-CSF and IL-3 (16) . These findings support the hypothesis that M-CSF plays an important role not only in the growth of osteoclast progenitors but also in their terminal differentiation into mature osteoclasts.
In the present study, we have attempted to separate the process of osteoclast development into two phases, proliferative phase and differentiation phase, to elucidate the mechanism of action of M-CSF in osteoclast development. We report here that M-CSF is critical not only for proliferation of osteoclast progenitors but also for their terminal differentiation into mature osteoclasts.
Methods
Antibodies and chemicals. Goat anti-mouse M-CSF antiserum (anti-M-CSF antibody) ( 17) and anti-mouse c-fms/M-CSF receptor antiserum (anti-c-fms antibody) ( 18) were prepared as described. These antibodies added at 0.1% were sufficient to inhibit colony formation of mouse marrow cells induced by murine M-CSF. Anti-mouse GM-CSF polyclonal antibody (anti-GM-CSF antibody) was kindly provided by Sumitomo Pharmaceutical Co. (Osaka, Japan). This antibody added at 0.4% completely inhibited the DNA synthesis in mouse marrow cells induced by 2 ng/ml of murine GM-CSF. la,25(0H)2D3 was purchased from Philips-Duphar (Amsterdam, The Netherlands). Salmon calcitonin was kindly supplied by Chugai Pharmaceutical Co. (Tokyo, Japan). ['25I]salmon calcitonin was prepared as previously described (19) . The specific activity of the product was 18. In the experiment assessing [ 3H ] thymidine incorporation, the radioisotope (3.7 x 10' Bq/0.5 ml) was added to co-cultures on day 6. After incubation for 12 h, cells were washed twice with ice-cold PBS. The radioactivity incorporated into TCA-insoluble fractions was counted in scintillation fluid (ACS II; Amersham Corp., Arlington Heights, IL). For autoradiographic studies, co-cultures were performed on coverslips (13.5 mm; Sumitomo Bakelite Co., Tokyo, Japan) placed in 24-well plates. [ 3H I Thymidine (3.7 x 104 Bq/0.5 ml) was added to the co-cultures for 12 h either on day 3 or day 5. In some experiments, co-cultures were treated with 1 mM hydroxyurea together with Ia,25(OH)2D3 for the final 2 d ofculture to inhibit cell proliferation. 1 mM hydroxyurea was sufficient to inhibit completely DNA synthesis in our co-cultures. After being cultured for 6 d, cells were fixed, stained for TRAP, and processed for autoradiography as described previously (21 ) . Nuclei which contained > 50 grains were counted as labeled nuclei. Statistical analysis. Each series ofexperiments was repeated at least three times. The results obtained from a typical experiment were expressed as the means±SEM (standard error ofthe mean) ofquadruplicate cultures. Significant differences were determined using Student's t test.
Results
When mouse spleen cells were co-cultured for 6 d with mouse osteoblastic cells in the presence of 10 nM la,25(OH)2D3, a number of osteoclast-like MNCs were formed in response to the vitamin (Fig. 1 ). Adding 1 a,25 (OH)2D3 only for the final 2 d of the 6-d co-culture period also induced osteoclast-like MNC formation, though the number of osteoclast-like MNCs formed was slightly smaller than that observed when the vitamin was added throughout the co-culture period (Fig. 1) . A small number of osteoclast-like MNCs were also formed in control co-cultures after the cells had been cultured for 6 d without 1a,25(OH)2D3, but no osteoclast-like MNCs appeared on day 4 even in co-cultures treated with 1 a,25 (OH)2D3 (Fig. 1) Fig. 2 A) . Many osteoblastic cells also contained labeled nuclei. When the labeling was performed on day 5 in the absence of hydroxyurea, only 7.3% of the nuclei in osteoclast-like MNCs formed in response to 1a,25 (OH)2D3 were labeled with [3H]thymidine (Fig. 2 B and Table II ). The number of osteoclast-like MNCs formed in cocultures labeled with [3H ]thymidine on day 3 was much less, as compared with the number obtained in co-cultures labeled on day 5 (Table II) . Even when hydroxyurea was not added to the co-cultures labeled with [3H]thymidine on day 3, the number of osteoclast-like MNCs formed in response to 1 a,25 (OH)2D3 was similarly decreased (data not shown). This suggests that in the proliferative phase, osteoclast progenitors are highly sensitive to radioactive thymidine. From these results, we concluded that osteoclast progenitors mostly proliferate during the first 4 days (proliferative phase) and that their differentiation into osteoclast-like MNCs occurs preferentially during the final 2 d of culture in the absence of appreciable DNA synthesis (differentiation phase).
To examine how M-CSF is involved in osteoclast development, co-cultures were treated with anti-M-CSF antibody, anti-c-fms antibody, and anti-GM-CSF antibody during the proliferative phase (the first 4 d) or during the differentiation phase (the final 2 d). Fig. 3 shows the dose-response effect of these antibodies added either during the first 4 d (Fig. 3 A) or during the final 2 d (Fig. 3 B) on osteoclast-like MNC formation induced by 1 a,25 (OH)2D3. In either case, anti-M-CSF antibody and anti-c-fms antibody inhibited osteoclast-like MNC formation dose-dependently (Fig. 3, A and B) . The appearance of TRAP-positive mononuclear cells (possibly precursors of osteoclast-like MNCs) was also suppressed by treatment with the respective antibodies (data not included). In contrast, neither osteoclast-like MNC formation nor TRAP-positive mononuclear cell formation induced by lIa,25 (0H)2D3 was inhibited by adding anti-GM-CSF antibody both in the proliferative phase and differentiation phase (Fig. 3, A and B) . In either case, preimmune serum had no inhibitory effect on osteoclast-like MNC formation (data not shown).
To further investigate the importance of M-CSF in osteoclast development, we performed co-cultures of normal spleen cells obtained from ddy mice and osteoblastic cells from op/op mice, which do not produce functionally active M-CSF. When recombinant human M-CSF was present at 100 ng/ml throughout the 6-d co-culture period, osteoclast-like MNCs were formed in response to 1 a,25 (OH)2D3, which was added only for the final 2 d (Fig. 4) . Osteoclast-like MNCs were also formed even in the presence of hydroxyurea, which was added at 1 mM for the final 2 d together with 1a,25 (OH)2D3 (Fig. 4) . However, lack of M-CSF either for the first 4 d (proliferative phase) or for the final 2 d (differentiation phase) failed to form osteoclast-like MNCs almost completely (Fig. 4 ). These results demonstrate that M-CSF is required both in the proliferative phase and in the differentiation phase of osteoclast development. 
Discussion
The present study clearly shows that the 6-d culture period of our co-culture system can be separated into two phases: the first 4 d, in which the proliferation of osteoclast progenitors primarily occurs, and the final 2 d, in which their differentiation into mature osteoclasts is predominant. First, no TRAPpositive osteoclast-like MNCs appeared on day 4 even in the presence of 1 a,25 (OH )2D3 (Fig. 1) . Second, TRAP-positive MNCs were formed during the final 2 d of culture in response to 1 a,25 (OH )2D3 even under conditions in which DNA synthesis was almost completely inhibited by the addition of 1 mM hydroxyurea (Table I) (22) reported that proliferation of osteoclast progenitors in embryonic mouse metatarsal bones was sensitive to ionizing irradiation, but the formation of multinucleated osteoclasts was relatively resistant. Using a modified co-culture system, we examined the role of M-CSF in osteoclast development. M-CSF is a growth factor responsible for proliferation, differentiation and survival of hemopoietic cells of the monocyte-macrophage lineage (23) . tem (16) . However, in the present study, anti-GM-CSF antiiti-GM-CSF body added during the proliferative phase failed to suppress osteoclast formation. We also confirmed that the proliferation of macrophages maintained on the op/op osteoblastic cells was very poor (unpublished observation), though GM-CSF was normally produced by op/op osteoblastic cells (8) . These results indicate that in this modified co-culture system, osteoclast progenitors proliferated preferentially in response to M-CSF. This notion is in accordance with that of Corboz et al. (24), who reported that irradiation inhibited the M-CSF-induced ti-c-tms bone resorption in a mouse metatarsal bone culture system. It iM-CsF is therefore concluded that M-CSF is important as a proliferation factor of osteoclast progenitors. Addition ofeither anti-M-CSF antibody or anti-c-fms antibody to co-cultures during the differentiation phase also suppressed the appearance of TRAP-positive MNCs dose-dependently (Fig. 3 B) . As was shown in the experiments with hydroxyurea, differentiation ofprecursor cells into osteoclast-like anti-GM-CSF MNCs occurred by a mechanism independent of cell growth during the final 2 d of culture ( Fig. 1 and Table I ). Anti-GM-CSF antibody added during the differentiation phase did not affect osteoclast-like MNC induction by la,25(OH)2D3
( Fig. 3 B) .
Experiments using osteoblastic cells obtained from op/op mouse calvaria made our conclusion more convincing. (Fig. 3 A) . This indicates that M-CSF is necessary for promoting proliferation ofosteoclast progenitors. Similar results were obtained in experiments with anti-c-fms antibody, but anti-GM-CSF antibody had no inhibitory effect (Fig. 3 A) . We previously reported that M-CSF was the most efficient stimulator of osteoclast progenitor proliferation, but that GM-CSF and IL-3 could be substituted for M-CSF to some extent in producing this effect in two-step co-culture sys- larly formed in response to Ia,25(OH)2D3 even in the presence of 1 mM hydroxyurea which was added during the last 2 d (Fig. 4) . In contrast, lack of M-CSF either in the proliferative phase or in the differentiation phase failed to form osteoclastlike MNCs (Fig. 4) . These results clearly demonstrate that M-CSF plays a critical role in inducing not only proliferation of osteoclast progenitors but also their differentiation into mature osteoclasts. This is consistent with the finding of Hattersley et al., who reported that GM-CSF increased the appearance of F4/ 80-positive macrophages but not osteoclasts in co-cultures of op/op osteoblastic cells and normal spleen cells (25). The action ofM-CSF has been reported to be mediated by a specific receptor encoded by the c-fms protooncogene, which exhibits tyrosine kinase activity (26 (27) . Therefore, in our co-cultures of osteoblastic cells and spleen cells, the target cells of M-CSF are probably osteoclast progenitors. Signal transduction pathways through M-CSF receptors have been investigated in bone marrow-derived macrophages and several established cell lines of the monocyte-macrophage lineage. In the M-CSF (CSF-1)-dependent mouse macrophage cell line BAC 1 .2F5, M-CSF stimulated the rapid tyrosine phosphorylation of several, predominantly cytoplasmic, proteins (18, 28, 29) that was followed by serine phosphorylation of the cytoplasmic protooncogene product, RAF-1, and activation of the RAF-1-associated seine kinase (30) . Using a murine macrophage cell line, P388D 1, Varticovski et al. reported that M-CSF receptors activated phosphatidylinositol-3 kinase, which may play an important role in the signal transduction pathway of M-CSF (31 ) . It was also shown that M-CSF was required by bone marrow-derived macrophages during the G1 phase to ensure both cell survival and entry into the S phase, but was no longer required after cells had entered the S phase (32) . More recently, Matsushime et al. (33) reported that regulators ofthe G 1 / S transition could be cyclin-like proteins whose expression was regulated by M-CSF. It is not known whether such M-CSF signal transduction pathways are also important in the development of osteoclasts. Most of the work so far reported points to an important role for M-CSF as a mitogen ofmonocyte-macrophage lineage cells, but very little is known about the mechanism of action of M-CSF in cell differentiation. Therefore, the in vitro system for osteoclast development used in this study will be a useful model for investigating the role ofM-CSF in cell differentiation. Further studies are needed to elucidate the mechanism underlying the signal transduction induced by M-CSF-activated tyrosine kinase and osteotropic hormones in osteoclast development.
